Oxford - Oxford Biomedica plc , a quality and innovation-led cell and gene therapy CDMO, and Institut Merieux SA today announce that they have entered into exclusive negotiations with respect to the.
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation No. 596/2014 Act 2018). Upon the.
Tempur Sealy Completes Acquisition Of Dreams prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.